SPDR S&P Biotech ETF (XBI) Shares Sold by Cetera Advisor Networks LLC

Cetera Advisor Networks LLC lowered its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 22.4% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 16,625 shares of the exchange traded fund’s stock after selling 4,787 shares during the period. Cetera Advisor Networks LLC’s holdings in SPDR S&P Biotech ETF were worth $1,505,000 as of its most recent filing with the SEC.

Several other institutional investors have also bought and sold shares of the company. Quattro Financial Advisors LLC raised its holdings in shares of SPDR S&P Biotech ETF by 49.6% during the 4th quarter. Quattro Financial Advisors LLC now owns 374 shares of the exchange traded fund’s stock worth $31,000 after buying an additional 124 shares in the last quarter. Creative Financial Designs Inc. ADV raised its holdings in shares of SPDR S&P Biotech ETF by 5.5% during the 1st quarter. Creative Financial Designs Inc. ADV now owns 2,402 shares of the exchange traded fund’s stock worth $217,000 after buying an additional 125 shares in the last quarter. Equitable Trust Co. raised its holdings in shares of SPDR S&P Biotech ETF by 2.6% during the 4th quarter. Equitable Trust Co. now owns 5,121 shares of the exchange traded fund’s stock worth $367,000 after buying an additional 129 shares in the last quarter. Mitchell Sinkler & Starr PA raised its holdings in shares of SPDR S&P Biotech ETF by 2.5% during the 4th quarter. Mitchell Sinkler & Starr PA now owns 6,190 shares of the exchange traded fund’s stock worth $444,000 after buying an additional 150 shares in the last quarter. Finally, Elite Wealth Management Inc. raised its holdings in shares of SPDR S&P Biotech ETF by 1.8% during the 4th quarter. Elite Wealth Management Inc. now owns 9,065 shares of the exchange traded fund’s stock worth $650,000 after buying an additional 160 shares in the last quarter.

SPDR S&P Biotech ETF stock opened at $82.46 on Thursday. SPDR S&P Biotech ETF has a 52 week low of $64.38 and a 52 week high of $101.55.



WARNING: This piece was originally reported by Dakota Financial News and is the sole property of of Dakota Financial News. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of international copyright & trademark legislation. The legal version of this piece can be viewed at https://dakotafinancialnews.com/2019/05/16/spdr-sp-biotech-etf-xbi-shares-sold-by-cetera-advisor-networks-llc.html.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Read More: What is the Russell 2000 Index?

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.